Evaluation of the financial performances of the medical device companies among Fortune 500 companies before, during and after the COVID-19 pandemic
Authors:
- Tolga TümerTTTolga Tümer
- Dilaver TengilimoğluDTDilaver Tengilimoğlu
- Eşref Uğur ÇelikEÇEşref Uğur Çelik
- Emine Kübra Dindar DemirayEDEmine Kübra Dindar Demiray
Preprint
- 8 January 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
The purpose of this study was to evaluate the financial performances of the six medical device companies among Fortune 500 companies before, during and after the COVID-19 pandemic. We first conducted ratio analysis by using liquidity, turnover, leverage and profitability ratios; then we conducted Wilcoxon signed-rank tests by using the calculated values of the financial ratios. We obtained the required data from the annual financial statements of the medical device companies among Fortune 500 companies. In the analyses, we took 2019 as the year before the COVID-19 pandemic, 2020 and 2021 as the year of the COVID-19 pandemic and 2022 as the year after the COVID-19 pandemic. The medical device companies among Fortune 500 companies were able to keep their financial performances strong when the COVID-19 pandemic began; they were able to increase their profits in the second year of the COVID-19 pandemic; and they were able to start using their assets more efficiently after the COVID-19 pandemic. The findings of the study suggests that the overall financial performances of the medical device companies among Fortune 500 companies were strong before, during and after the COVID-19 pandemic. The evaluation of the financial performances of the medical device companies among Fortune 500 companies before, during and after the COVID-19 pandemic may be beneficial for managers and policy makers in the medical device industry to determine the areas that requires to be strengthened in order to be better prepared for possible future pandemics and crisis periods.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- The Effect of Perceived Social Support by Healthcare Professionals on Emotional Exhaustion during the Covid-19 ProcessCumhuriyet Üniversitesi İktisadi ve İdari Bilimler Dergisi, 2022
- The impact of COVID-19 on hospitals’ financial performance: Evidence from California hospitalsInternational Journal of Healthcare Management, 2022
- Improving resilience of the healthcare supply chain in a pandemic: Evidence from Europe during the COVID-19 crisisJournal of Purchasing and Supply Management, 2022
- Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectivesBest Practice & Research Clinical Anaesthesiology, 2021
- COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social ResponsibilityFrontiers in Public Health, 2021
- Influence of epidemic COVID–19 on business strategy, information technology and supply chain agility to firm performance in medical device industryLinguistics and Culture Review, 2021
- Financial performance of China’s listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibilityCurrent Psychology, 2021
- Coronavirus (Covid-19) and entrepreneurship: cultural, lifestyle and societal changesJournal of Entrepreneurship in Emerging Economies, 2020
- COVID-19: ensuring our medical equipment can meet the challengeExpert Review of Medical Devices, 2020
- Towards Stronger EU Governance of Health Threats after the COVID-19 PandemicEuropean Journal of Risk Regulation, 2020